Volume 45, Issue 1 pp. 13-19

Fate of Newborn Dentate Granule Cells after Early Life Status Epilepticus

Brenda E. Porter

Brenda E. Porter

Division of Pediatric Neurology, The Children's Hospital of Philadelphia, and Departments of Neurology and Pediatrics at the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, U.S.A.

Search for more papers by this author
Margaret Maronski

Margaret Maronski

Division of Pediatric Neurology, The Children's Hospital of Philadelphia, and Departments of Neurology and Pediatrics at the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, U.S.A.

Search for more papers by this author
Amy R. Brooks-Kayal

Amy R. Brooks-Kayal

Division of Pediatric Neurology, The Children's Hospital of Philadelphia, and Departments of Neurology and Pediatrics at the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, U.S.A.

Search for more papers by this author
First published: 24 December 2003
Citations: 31
Address correspondence and reprint requests to Dr. B.E. Porter at Division of Child Neurology, 6 Wood, The Children's Hospital of Philadelphia, 34th and Civic Center Boulevard, Philadelphia, PA 19104, U.S.A. E-mail: [email protected]

Abstract

Summary:  Purpose: To determine the fate of newborn dentate granule cells (DGCs) after lithium-pilocarpine–induced status epilepticus (SE) in an immature rat.

Methods: Postnatal day 20 (P20) rats were injected with lithium and pilocarpine to induce SE, and then with bromodeoxyuridine (BrdU) 4, 6, and 8 days later (P24, 26, and 28), and killed 1 day (P29), 1 week (P34), and 3 weeks (P50) after the last dose of BrdU for cell counts. Immunohistochemistry and TUNEL staining were performed to assess the fate of newborn DGCs.

Results: Pilocarpine-treated animals had significantly more BrdU-labeled DGCs than did littermate controls at all times. The day after the final BrdU injection (P29), sixfold more cells were found in pilocarpine-treated animals than in controls, which was reduced to threefold, 3 weeks later. A decrease in the BrdU-labeled cell density was noted from P29 to P50 in the control and pilocarpine-treated animals. Evidence of DGC cell death was seen in pilocarpine and control animals, with threefold more TUNEL-positive cells in the pilocarpine-treated than in the control animals at P29. The surviving newborn DGCs became mature neurons; expressing the neuronal marker NeuN in both control and pilocarpine-treated animals.

Conclusions: These findings suggest that SE during postnatal development increases the birth and death of DGCs. A subset of the newborn DGCs survive and mature into dentate granule neurons, resulting in an increased population of immature DGCs after SE that may affect hippocampal physiology.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me